NASDAQ
Kronos Bio, Inc. (KRON) has a fcf yield of -114.67% as of Friday, May 29, 2026. This represents a 99.71% decrease compared to its 12-month average of -57.42%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.